Sandoz Will Not Pursue US Advair Rival

Discontinuing Development Leads To $442m Impairment

 
• By David Wallace
  
Sportsman_Tired
Sandoz has given up on the race for a generic version of Advair Diskus • Source: Shutterstock

More from Strategy

More from Business